{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:16:45Z","timestamp":1790839005370,"version":"4.1.0"},"reference-count":255,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.atherosclerosis.2004.10.022","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T22:59:26Z","timestamp":1105138766000},"page":"1-15","source":"Crossref","is-referenced-by-count":24,"title":["What causes acute coronary syndromes? Applying Koch's postulates"],"prefix":"10.1016","volume":"179","author":[{"given":"Claudia","family":"Monaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib1","unstructured":"Koch R. Classics in infectious diseases. The etiology of tuberculosis: Robert Koch, Berlin, Germany, 1882."},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib2","first-page":"648","article-title":"Stenoses in the coronary arteries","volume":"53","author":"Solberg","year":"1985","journal-title":"Oslo Study Lab Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib3","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","article-title":"High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound","volume":"103","author":"Tuzcu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/oxfordjournals.eurheartj.a062449","article-title":"Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe","volume":"9","author":"Hackett","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0735-1097(88)90356-7","article-title":"Angiographic progression of coronary artery disease and the development of myocardial infarction","volume":"12","author":"Ambrose","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0368-1319(66)80056-X","article-title":"Plaque fissuring in human coronary thrombosis","volume":"6","author":"Costantidines","year":"1966","journal-title":"LJ Atheroscler Res"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2004.10.022_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0049-3848(74)90144-3","article-title":"Mechanisms and frequency of thrombosis in the coronary circulation","volume":"4","author":"Chandler","year":"1974","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/hrt.50.2.127","article-title":"Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis","volume":"50","author":"Falk","year":"1983","journal-title":"Br Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198405033101801","article-title":"Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death","volume":"310","author":"Davies","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.53.4.363","article-title":"Plaque fissuring\u2014the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina","volume":"53","author":"Davies","year":"1985","journal-title":"Br Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","article-title":"Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and\/or sudden death","volume":"71","author":"Falk","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.eurheartj.a059467","article-title":"Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death","volume":"10","author":"Davies","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib13","first-page":"II38","article-title":"A macro and micro view of coronary vascular insult in ischemic heart disease","volume":"82","author":"Davies","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0735-1097(91)90805-J","article-title":"Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction","volume":"18","author":"Kragel","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib15","first-page":"III-30","article-title":"Why do plaques rupture?","volume":"86","author":"Falk","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.69.5.377","article-title":"Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content","volume":"69","author":"Davies","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib17","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","article-title":"Stability and instability: two faces of coronary atherosclerosis","volume":"94","author":"Davies","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0735-1097(97)00213-1","article-title":"Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes","volume":"30","author":"Depre","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib20","first-page":"II47","article-title":"Atherosclerotic plaque rupture and thrombosis","volume":"82","author":"Fuster","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"Van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib22","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.CIR.93.7.1354","article-title":"Coronary plaque erosion without rupture into a lipid core","volume":"93","author":"Farb","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","article-title":"Coronary risk factors and plaque morphology in men with coronary disease who died suddenly","volume":"336","author":"Burke","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib25","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib26","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa035655","article-title":"Intraplaque hemorrhage and progression of coronary atheroma","volume":"349","author":"Kolodgie","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0735-1097(86)80455-7","article-title":"Angiographic evolution of coronary artery morphology in unstable angina","volume":"7","author":"Ambrose","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.80.1.17","article-title":"Intracoronary thrombus and complex morphology in unstable angina","volume":"80","author":"Freeman","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0735-1097(87)80321-2","article-title":"Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction","volume":"9","author":"Ambrose","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0735-1097(96)00560-8","article-title":"Correlation of angiographic morphology and clinical presentation in unstable angina","volume":"29","author":"Dangas","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198610093151501","article-title":"Coronary angioscopy in patients with unstable angina pectoris","volume":"315","author":"Sherman","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0140-6736(91)92514-3","article-title":"Angioscopic coronary macromorphology in patients with acute coronary disorders","volume":"337","author":"Mizuno","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM199201303260502","article-title":"Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes","volume":"326","author":"Mizuno","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(96)00108-8","article-title":"Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes","volume":"28","author":"Thieme","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0735-1097(96)00102-7","article-title":"Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients","volume":"28","author":"Feld","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib37","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jacc.2003.06.003","article-title":"Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study","volume":"42","author":"Sakai","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib38","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/01.ATV.17.10.1859","article-title":"The unstable atheroma","volume":"17","author":"Lee","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0854.2003.8042.x","article-title":"Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque","volume":"16","author":"Virmani","year":"2003","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib41","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1161\/01.CIR.102.21.2582","article-title":"Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging","volume":"102","author":"Botnar","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.104.3.249","article-title":"Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib43","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/01.CIR.98.15.1541","article-title":"Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice","volume":"98","author":"Fayad","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.CIR.102.5.506","article-title":"Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging","volume":"102","author":"Fayad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.102.9.959","article-title":"Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging","volume":"102","author":"Hatsukami","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib46","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V93.9.2951","article-title":"Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells","volume":"93","author":"Mutin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib47","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.94.5.932","article-title":"Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo","volume":"94","author":"Toussaint","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(89)90953-7","article-title":"Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques","volume":"2","author":"Richardson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib51","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1073\/pnas.96.12.6920","article-title":"Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice","volume":"96","author":"Caligiuri","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib52","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib53","doi-asserted-by":"crossref","first-page":"II-38","DOI":"10.1002\/j.1932-8737.1997.tb00011.x","article-title":"Plaque disruption and coronary thrombosis: new insight into pathogenesis and prevention","volume":"20","author":"Shah","year":"1997","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib54","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0735-1097(02)02376-8","article-title":"Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction","volume":"40","author":"Spagnoli","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.1711710311","article-title":"The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis","volume":"171","author":"Davies","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib56","first-page":"200","article-title":"The expression of adhesion molecules on endothelial cells in atherosclerosis has a topographic relationship with the underlying inflammatory process","volume":"24","author":"Van der Wal","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib57","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.80.3.466","article-title":"Flow-dependent coronary artery dilatation in humans","volume":"80","author":"Drexler","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.79.5.1043","article-title":"Direct vasoconstriction and endothelium-dependent vasodilation","volume":"79","author":"Hodgson","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib59","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.CIR.80.3.458","article-title":"Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans","volume":"80","author":"Cox","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib60","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0735-1097(89)90416-6","article-title":"Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis","volume":"14","author":"Vita","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0735-1097(89)90414-2","article-title":"Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium","volume":"14","author":"Zeiher","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJM199407283310402","article-title":"Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction","volume":"331","author":"Uren","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(94)90082-5","article-title":"Effect of cholesterol-supplemented diet in heritable hyperlipidemic Yoshida rats: functional and morphological characterization of thoracic aorta","volume":"106","author":"Chinellato","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(93)90265-V","article-title":"The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits","volume":"103","author":"Kroon","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.CIR.69.2.441","article-title":"Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis","volume":"69","author":"Kawachi","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib67","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.64.5.900","article-title":"Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis","volume":"64","author":"Shimokawa","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib68","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/0735-1097(89)90318-5","article-title":"Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries","volume":"13","author":"Shimokawa","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib69","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0735-1097(91)90854-3","article-title":"Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium","volume":"17","author":"Shimokawa","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib71","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/0140-6736(93)90634-S","article-title":"Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients","volume":"341","author":"Leung","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(95)91322-X","article-title":"Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication","volume":"346","author":"Stroes","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib73","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95","author":"O\u2019Driscoll","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib75","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2004.10.022_bib76","doi-asserted-by":"crossref","first-page":"SII5","DOI":"10.1016\/S0140-6736(99)90234-9","article-title":"Acute coronary syndromes: biology","volume":"353","author":"Fuster","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0038-1646375","article-title":"The structural biology of expression and function of tissue factor","volume":"66","author":"Edgington","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib78","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.175.4023.766","article-title":"Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies","volume":"175","author":"Zeldis","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib79","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib80","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1161\/01.CIR.94.12.3090","article-title":"Macrophages, smooth muscle cells, and tissue factor in unstable angina","volume":"94","author":"Moreno","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib81","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib82","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.ATV.12.10.1111","article-title":"Initiation and regulation of tissue factor-dependent blood coagulation","volume":"12","author":"Rapaport","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib83","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00001721-199606000-00005","article-title":"Transmission of a procoagulant signal from tissue factor-bearing cell to platelets","volume":"7","author":"Monroe","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib84","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue-factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib85","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1161\/01.CIR.90.4.1662","article-title":"Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina","volume":"90","author":"Jude","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib86","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood-2002-03-0902","article-title":"Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions","volume":"100","author":"Balasubramanian","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2000-8456","article-title":"Tissue factor on the loose","volume":"26","author":"Giesen","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib88","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood-borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib89","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.100.11.1215","article-title":"Dietary lipid lowering reduces tissue factor expression in rabbit atheroma","volume":"100","author":"Aikawa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib90","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.98.17.1776","article-title":"Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary l-arginine","volume":"98","author":"Corseaux","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib91","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1161\/01.CIR.101.22.2651","article-title":"Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis","volume":"101","author":"Hasenstab","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib92","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.99.14.1780","article-title":"Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions","volume":"99","author":"Badimon","year":"1999","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2004.10.022_bib93","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/00001721-200004001-00027","article-title":"Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis","volume":"11","author":"Arnljots","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib94","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mcp.2002.127740","article-title":"Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans","volume":"72","author":"Jilma","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib95","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/01.ATV.0000019732.25208.B8","article-title":"Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study","volume":"22","author":"Lev","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib96","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0735-1097(84)80060-1","article-title":"Scintigraphic detection of coronary artery thrombi in patients with acute myocardial infarction","volume":"4","author":"Fox","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.80.1.198","article-title":"Specific platelet mediators and unstable coronary artery lesions","volume":"80","author":"Willerson","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib98","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/01.CIR.91.4.941","article-title":"Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque","volume":"91","author":"Zeiher","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib99","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM197812072992303","article-title":"Coronary vasospasm as a possible cause of myocardial infarction","volume":"299","author":"Maseri","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.90.1.5","article-title":"Vasoreactivity of the culprit lesion in unstable angina","volume":"90","author":"Bogaty","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib101","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","article-title":"Influence of platelet size on outcome after myocardial infarction","volume":"338","author":"Martin","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib102","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1055\/s-0037-1615952","article-title":"Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction","volume":"85","author":"Mathur","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2362.1994.tb02062.x","article-title":"Platelet glycoprotein IIb\u2013IIIa and size are increased in acute myocardial infarction","volume":"24","author":"Giles","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib104","first-page":"181","article-title":"Bleeding time and diagnosis of acute myocardial infarction","volume":"21","author":"Bath","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/24.1.19","article-title":"Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina","volume":"24","author":"Kristensen","year":"1990","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.54.3.365","article-title":"Platelet aggregation in partially obstructed vessels and its elimination with aspirin","volume":"54","author":"Folts","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib107","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.ATV.5.6.595","article-title":"Platelet interactions with Dacron vascular grafts","volume":"5","author":"Hanson","year":"1985","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI113286","article-title":"Effects of monoclonal antibodies against the platelet glycoprotein IIb\/IIIa complex on thrombosis and hemostasis in the baboon","volume":"81","author":"Hanson","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib109","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.98.22.2461","article-title":"Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates","volume":"98","author":"Harker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib110","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1055\/s-0037-1614907","article-title":"A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall\u2014studies in a porcine model","volume":"82","author":"Badimon","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib111","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib112","first-page":"81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy","volume":"308","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib113","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib114","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study","volume":"321","author":"Steering Committee of the Physicians\u2019 Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib117","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and Vitamin E in people at cardiovascular risk: a randomised trial in general practice","volume":"357","author":"de Gaetano","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib119","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.CIR.94.9.2083","article-title":"Effects of integrelin, a platelet glycoprotein IIb\/IIIa receptor antagonist, in unstable angina","volume":"94","author":"Schulman","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib121","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","article-title":"International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib122","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib123","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0002-8703(76)80144-5","article-title":"Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man","volume":"91","author":"Erhardt","year":"1976","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib124","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0735-1097(89)90099-5","article-title":"Urinary fibrinopeptide A levels in ischemic heart disease","volume":"14","author":"Wilensky","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"Wilhelmsen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib126","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib127","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/0140-6736(93)92062-X","article-title":"Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study","volume":"342","author":"Meade","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib128","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-8703(87)90063-9","article-title":"Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib129","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.83.3.836","article-title":"Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease","volume":"83","author":"Yarnell","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/1047-2797(92)90097-A","article-title":"Association of coagulation factors and inhibitors with carotid artery atherosclerosis","volume":"2","author":"Wu","year":"1992","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.ATV.14.1.54","article-title":"Fibrinogen and factor VII in the prediction of coronary risk","volume":"14","author":"Heinrich","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib132","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.ATV.15.9.1269","article-title":"Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly","volume":"15","author":"Tracy","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib133","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","article-title":"A prospective study of fibrinogen and risk of myocardial infarction in the Physicians\u2019 Health Study","volume":"33","author":"Ma","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib134","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pcad.2004.02.003","article-title":"Role of thrombotic and fibrinolytic factors in acute coronary syndromes","volume":"46","author":"Saigo","year":"2004","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib135","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib136","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.CIR.69.3.605","article-title":"Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology","volume":"69","author":"Van de Werf","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib137","first-page":"397","article-title":"Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction","volume":"1","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib138","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib139","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","article-title":"The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib140","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","article-title":"Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib141","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.98.25.2805","article-title":"TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial","volume":"98","author":"Cannon","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib142","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","article-title":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib143","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib144","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.CIR.86.1.131","article-title":"Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome","volume":"86","author":"Bar","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.CIR.85.1.150","article-title":"Thrombolysis in unstable angina","volume":"85","author":"Freeman","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib146","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib147","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib148","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib149","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9149(97)00487-6","article-title":"Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease","volume":"80","author":"Klein","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib151","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199609123351103","article-title":"A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib152","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(98)07332-2","article-title":"Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib153","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.98.11.1064","article-title":"Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results","volume":"98","author":"Anand","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib154","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(92)90346-E","article-title":"Koch's postulates for cholesterol","volume":"71","author":"Brown","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","article-title":"Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study","volume":"70","author":"Assmann","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib156","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.274.2.131","article-title":"Serum total cholesterol and long-term coronary heart disease mortality in different cultures","volume":"274","author":"Verschuren","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib157","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.159.10.1104","article-title":"Clustering of metabolic factors and coronary heart disease","volume":"159","author":"Wilson","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib158","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archinte.152.7.1490","article-title":"Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial","volume":"152","author":"Neaton","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib159","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.CIR.81.5.1721","article-title":"The cholesterol facts","volume":"81","author":"LaRosa","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/bmj.308.6925.367","article-title":"By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?","volume":"308","author":"Law","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib161","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.308.6925.363","article-title":"Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study","volume":"308","author":"Law","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib162","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis","volume":"272","author":"Breslow","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib163","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib164","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Steinberg","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib166","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(99)00145-X","article-title":"Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations","volume":"34","author":"Flaker","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib167","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS, Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib168","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib169","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00001573-200111000-00013","article-title":"Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial","volume":"16","author":"Ahsan","year":"2001","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib171","doi-asserted-by":"crossref","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","author":"De Lemos","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib172","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"Early statin initiation and outcomes in patients with acute coronary syndromes","volume":"287","author":"Newby","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib173","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib174","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib175","doi-asserted-by":"crossref","first-page":"II42","DOI":"10.1161\/01.CIR.0000129500.29229.92","article-title":"Beyond the laboratory: clinical implications for statin pleiotropy","volume":"109","author":"Halcox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib176","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib177","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib178","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib179","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib180","first-page":"825","article-title":"Der atheromatose Prozess der Arterien","volume":"6","author":"Virchow","year":"1856","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib181","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib182","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1568010043483881","article-title":"T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases","volume":"3","author":"Monaco","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib183","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-9149(90)90482-G","article-title":"Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest","volume":"66","author":"Kragel","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib184","first-page":"166","article-title":"Atherosclerotic lesions in humans","volume":"61","author":"Van der Wal","year":"1989","journal-title":"Lab Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-9150(97)00135-4","article-title":"Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation","volume":"133","author":"de Boer","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib186","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0021-9150(88)90074-3","article-title":"Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques","volume":"72","author":"Hansson","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib187","first-page":"169","article-title":"Detection of activated T lymphocytes in the human atherosclerotic plaque","volume":"135","author":"Hansson","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib188","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0140-6736(93)92621-Y","article-title":"Immunological markers of atherosclerosis","volume":"341","author":"Hansson","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib189","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1136\/hrt.69.1_Suppl.S38","article-title":"Immune and inflammatory mechanisms in the development of atherosclerosis","volume":"69","author":"Hansson","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib190","first-page":"41","article-title":"Immunological control mechanisms in plaque formation","volume":"1","author":"Hansson","year":"1994","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib191","first-page":"1427","article-title":"Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions","volume":"141","author":"Van der Wal","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib192","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","article-title":"Detection and localization of tumor necrosis factor in human atheroma","volume":"65","author":"Barath","year":"1990","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2004.10.022_bib193","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.5551\/jat1994.1.Supplemment1_S10","article-title":"Local expression of inflammatory cytokines in human atherosclerotic plaques","volume":"1","author":"Wilcox","year":"1994","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib194","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-199500252-00003","article-title":"Cytokines regulate vascular functions related to stability of the atherosclerotic plaque","volume":"25","author":"Libby","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.76.4.312","article-title":"Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques","volume":"76","author":"Van der Wal","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib196","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/hrt.80.1.14","article-title":"Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes","volume":"80","author":"Van der Wal","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib197","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9343(03)00078-0","article-title":"Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation","volume":"114","author":"Meuwissen","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib198","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0735-1097(01)01133-0","article-title":"Recurrent unstable angina after directional coronary atherectomy is related to the extent of initial coronary plaque inflammation","volume":"37","author":"Meuwissen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib199","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9150(03)00024-8","article-title":"Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction","volume":"168","author":"Hosono","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib200","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/01.CIR.91.8.2125","article-title":"Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions","volume":"91","author":"Brown","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib201","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMoa012295","article-title":"Widespread coronary inflammation in unstable angina","volume":"347","author":"Buffon","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib202","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM199704033361409","article-title":"atherosclerosis and ischemic events\u2014exploring the hidden side of the moon","volume":"336","author":"Maseri","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib203","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.86.3.790","article-title":"Transient intermittent lymphocyte activation is responsible for the instability of angina","volume":"86","author":"Neri Serneri","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib204","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.95.7.1806","article-title":"Acute T-cell activation is detectable in unstable angina","volume":"95","author":"Neri Serneri","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib205","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0735-1097(98)00410-0","article-title":"Immune system activation follows inflammation in unstable angina: pathogenetic implications","volume":"32","author":"Caligiuri","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib206","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0735-1097(90)92826-N","article-title":"Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction","volume":"15","author":"Dinerman","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib207","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.CIR.79.3.549","article-title":"Neutrophil function in ischemic heart disease","volume":"79","author":"Mehta","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib208","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.CIR.88.2.358","article-title":"Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease","volume":"88","author":"Mazzone","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib209","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0735-1097(95)00524-2","article-title":"Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia","volume":"27","author":"Biasucci","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib210","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/0735-1097(95)00308-8","article-title":"Clinical and angiographic correlates of leukocyte activation in unstable angina","volume":"26","author":"De Servi","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib211","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib212","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","article-title":"Elevated levels of interleukin-6 in unstable angina","volume":"94","author":"Biasucci","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib213","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib214","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","article-title":"C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease)","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.312.7038.1061","article-title":"C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study","volume":"312","author":"Mendall","year":"1996","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib216","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris","volume":"332","author":"Thompson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib217","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.CIR.99.7.855","article-title":"Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib218","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib219","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017493.03108.1C","article-title":"Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death","volume":"105","author":"Albert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib220","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib221","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib222","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib223","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-a and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib224","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib225","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.ATV.10.2.178","article-title":"Atherogenesis during low-level hypercholesterolemia in the non-human primate","volume":"10","author":"Masuda","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib226","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.ATV.20.1.10","article-title":"Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice","volume":"20","author":"Paulsson","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib227","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib228","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib229","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/hh0901.090440","article-title":"Anti-inflammatory mechanisms in the vascular wall","volume":"88","author":"Tedgui","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib230","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib231","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00041433-200310000-00004","article-title":"Oxidized low density lipoprotein and innate immune receptors","volume":"14","author":"Miller","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib232","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11883-999-0011-0","article-title":"Inflammation and immune response in atherosclerosis","volume":"1","author":"Hansson","year":"1999","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib233","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00019501-199312000-00014","article-title":"Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk","volume":"4","author":"Maggi","year":"1993","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib234","first-page":"1158","article-title":"Autoantibodies against oxidised low density lipoproteins in patients with coronary disease","volume":"23","author":"Maggi","year":"1994","journal-title":"Presse Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib235","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/euhj.2000.2554","article-title":"Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease: pathophysiological implications","volume":"22","author":"Monaco","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib236","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/clc.4960251005","article-title":"Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study","volume":"25","author":"Crea","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib237","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.311.7007.711","article-title":"Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors","volume":"311","author":"Patel","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib238","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0021-9150(98)00115-4","article-title":"Animal models for Chlamydia pneumoniae infection","volume":"140","author":"Saikku","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib239","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-116-4-273","article-title":"Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study","volume":"116","author":"Saikku","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib240","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0735-1097(98)00093-X","article-title":"Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease","volume":"31","author":"Mehta","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib241","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.71.5.437","article-title":"Relation of Helicobacter pylori infection and coronary heart disease","volume":"71","author":"Mendall","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib242","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.97.17.1671","article-title":"Inflammation, infection, and cardiovascular risk: how good is the clinical evidence?","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib243","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.99.9.1161","article-title":"Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction","volume":"99","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib244","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/clc.4960220206","article-title":"Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease","volume":"22","author":"Altman","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bmj.321.7255.204","article-title":"Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study","volume":"321","author":"Wald","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib246","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07201-2","article-title":"Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study","volume":"350","author":"Gurfinkel","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib247","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib248","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/01.CIR.0000078632.76653.6C","article-title":"Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes","volume":"107","author":"Biasucci","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib249","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/01.ATV.19.3.505","article-title":"Enhanced fatty streak formation in C57BL\/6J mice by immunization with heat shock protein-65","volume":"19","author":"George","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib250","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.102.8.833","article-title":"Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and Cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis","volume":"102","author":"Mayr","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib251","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.immunol.22.012703.104644","article-title":"Autoimmune and inflammatory mechanisms in atherosclerosis","volume":"22","author":"Wick","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib252","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.CIR.100.21.2135","article-title":"Perturbation of the T-cell repertoire in patients with unstable angina","volume":"100","author":"Liuzzo","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib253","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib254","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.022_bib255","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","article-title":"Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis","volume":"101","author":"Monaco","year":"2004","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004005611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004005611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T20:02:57Z","timestamp":1625342577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004005611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":255,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0021915004005611"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.10.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}